Health - Monday, June 15, 2026

The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.

A new study of bilingual speakers suggests that a single “grammatical engine” in the brain can power multiple languages at once.

After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.

For years, calcium and vitamin D supplements have been promoted as a simple way for older adults to protect their bones and prevent falls. But a massive review of nearly 154,000 people found that calcium, vitamin D, or a combination of both provided little to no meaningful protection against fractures or falls for most older adults.

A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.

A large-scale study suggests that men with higher levels of the amino acid tyrosine may have shorter lifespans, potentially losing close to a year of life expectancy. The finding is especially intriguing because tyrosine is commonly associated with brain health and is often used in supplements aimed at boosting focus and performance.

Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.

A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout

The United States is reliant on unpaid family caregivers, and millions of adult children are caring for parents who didn’t really care for them.

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes treatments may soon become available in a much more convenient pill form.